Abstract
Bcr-Abl oncoproteins are responsible for the pathogenesis of human leukemias with a reciprocal chromosome translocation t(9;22). The amino- terminal Bcr sequence has a potential to form a homotetramer (tetramer domain), and destructions of the tetramer domain cause a complete loss of biological activities in Bcr-Abl. Here we show that Bcr-Abl in which the tetramer domain is replaced with glutathione S-transferase (GST) with a dimerizing ability (GST/Bcr-Abl-(Δ1-160)) can no longer induce an interleukin-3 (IL-3) independence in Ba/F3 cells or transform mouse bone marrow cells but still retains by 30-40% the ability to transform Rat1 cells. Compared with the wild type Bcr-Abl, autophosphorylation of GST/Bcr-Abl- (Δ1-160) in vivo was reduced by more than 50%. The Grb-2 binding to GST/Bcr- Abl-(Δ1-160) was 50% reduced in Rat1 cells and undetectable in Ba/F3 cells. In Rat1 cells expressing GST/Bcr-Abl-(Δ1-160), phosphotyrosine contents of p62 and Shc were 70% decreased.
Cite
CITATION STYLE
Maru, Y., Afar, D. E., Witte, O. N., & Shibuya, M. (1996). The dimerization property of glutathione S-transferase partially reactivates Bcr-Abl lacking the oligomerization domain. Journal of Biological Chemistry, 271(26), 15353–15357. https://doi.org/10.1074/jbc.271.26.15353
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.